Study Links Maternal Postpartum Depression to Increased Infant Mortality Risk

The research, published in JAMA Network Open, examined birth records from 2016 to 2020, linking them with infant death data through 2021. The study found an infant mortality rate of 7.2 deaths per 1,000 births among infants whose mothers reported depressive symptoms, contrasted with 2 deaths per 1,000 births for those whose mothers did not report such symptoms. After adjusting for various maternal and infant demographic and socioeconomic factors, infants of mothers with depressive symptoms were nearly three times more likely to die before age 1, regardless of race, education, insurance status, or whether the baby was born full term or prematurely.

Rebecca Woofter, the study's lead author and a postdoctoral associate at the Rutgers School of Public Health, noted the consistency of these findings across diverse groups. She emphasized the importance of further understanding the relationship between maternal depression and infant mortality, stating, "These findings don't mean that maternal depression is causing infant deaths, but it does tell us there is an important relationship here that we need to understand much better."

New Jersey's requirement for universal screening of postpartum depressive symptoms contributes to the study's robustness. Hospitals use the Edinburgh Postnatal Depression Scale for this purpose, with results recorded in birth records. This methodology allows the researchers to identify depressive symptoms without relying solely on clinical diagnoses, which can be overlooked in many cases.

The study also explored leading causes of infant mortality in New Jersey, revealing that maternal depressive symptoms were linked to increased risks of death related to prematurity, perinatal conditions, congenital malformations, chromosomal abnormalities, and sudden infant death syndrome. However, the exact mechanisms behind the association remain unclear. Maternal depression could lead to adverse birth outcomes, changes in health behaviors, or may correlate with challenging social and economic conditions that affect family resources.

Though the study highlights a significant association, it does not establish a causal relationship between maternal depressive symptoms and infant mortality. Other unmeasured factors may also play a role in these findings.

The implications of this research stress the need for improved maternal mental health as part of the broader conversation on infant health. Woofter called for a continuity of health care for both mothers and infants post-delivery.

Despite existing recommendations for screening during the perinatal period by organizations such as the American College of Obstetricians and Gynecologists, actual screening practices can differ widely. Identifying depressive symptoms does not guarantee diagnosis, referral, or treatment, indicating a gap in care that needs to be addressed.

"Screening gives us information at a point when almost every mother is still in the hospital," said Slawa Rokicki, the study's principal investigator. "But identifying symptoms is only the first step. Screening by itself isn't treatment; it must also be accompanied by effective referrals and access to appropriate treatment."

The study was conducted by Woofter, Rokicki, Mark McGovern, and Naomi Abe, a pediatrician at the University of California, San Francisco.